We first analyzed The Cancer Genome Atlas (TCGA) LAML (acute myeloid leukemia) dataset and found that higher levels of SREBF1 expression correlated with significantly worse patient outcome (p = 0.0007) in acute myeloid leukemia (Fig. 1A). The gene discussed is SREBF1; the disease is acute myeloid leukemia.